Industry Webcast

The Power of a First-in-Class Acid Suppressant: A Novel Treatment Option for Adults with GERD or H. Pylori InfectionIndustry Webcast Sponsored by Phathom Pharmaceuticals; Not for CME/CE Credit

Join us for an engaging session on therapeutic options for the treatment of GERD (gastroesophageal reflux disease) or H. pylori infection in adults. 

This product theater is sponsored by Phathom Pharmaceuticals and is not a continuing medical education program. The product theater content and views expressed therein are those of the sponsor and not of Pri-Med. © 2024 Phathom Pharmaceuticals

Watch

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 1/15/2025

Expiration Date: 7/15/2025

Faculty

Philip Schoenfeld, MD, MSEd, MSc

Learn More

Supporters and Partners

Industry Sponsor

Phathom Pharmaceuticals

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

The Power of a First-in-Class Acid Suppressant: A Novel Treatment Option for Adults with GERD or H. Pylori Infection

Watch